Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells
Zhiqiang Wang, Helen P. McWilliams-Koeppen, Hernan Reza, et al.
Cell stem cell (2022) Vol. 29, Iss. 4, pp. 515-527.e8
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 338
Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment
Ting Yan, Zhu Lingfeng, Jin Chen
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 108
Human organoids: New strategies and methods for analyzing human development and disease
Nina S. Corsini, Juergen A. Knoblich
Cell (2022) Vol. 185, Iss. 15, pp. 2756-2769
Open Access | Times Cited: 96
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 22
Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity
Jun Shen, Shuzhen Lyu, Yingxi Xu, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 1003-1019.e9
Closed Access | Times Cited: 18
The Progress and Prospects of Immune Cell Therapy for the Treatment of Cancer
Jia Han, B. Zhang, Senyu Zheng, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 17
Mechanisms and Strategies of Immunosenescence Effects on Non-Small Cell Lung Cancer (NSCLC) Treatment: A Comprehensive Analysis and Future Directions
Huatao Zhou, Zilong Zheng, Chengming Fan, et al.
Seminars in Cancer Biology (2025) Vol. 109, pp. 44-66
Closed Access | Times Cited: 2
EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity
Ran Jing, Irene Scarfo, Mohamad Najia, et al.
Cell stem cell (2022) Vol. 29, Iss. 8, pp. 1181-1196.e6
Open Access | Times Cited: 61
Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies
Frank Cichocki, Sjoukje J. C. van der Stegen, Jeffrey S. Miller
Blood (2022) Vol. 141, Iss. 8, pp. 846-855
Open Access | Times Cited: 46
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
Chunrun Qu, Hao Zhang, Hui Cao, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 45
Advancing cell-based cancer immunotherapy through stem cell engineering
Yan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 592-610
Open Access | Times Cited: 41
Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
Yang Zhou, Miao Li, Kuangyi Zhou, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2266-2266
Open Access | Times Cited: 40
Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapy
Dixuan Xue, Shan Lu, Hailing Zhang, et al.
Trends in biotechnology (2023) Vol. 41, Iss. 7, pp. 907-922
Open Access | Times Cited: 40
Biomaterial-based platforms for tumour tissue engineering
Rodrigo Curvello, Verena Kast, Paloma Ordóñez‐Morán, et al.
Nature Reviews Materials (2023) Vol. 8, Iss. 5, pp. 314-330
Open Access | Times Cited: 39
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 28
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Biomaterials to enhance adoptive cell therapy
Noah Eckman, Anahita Nejatfard, Romola Cavet, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 5, pp. 408-424
Closed Access | Times Cited: 14
Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation
Ratchapong Netsrithong, Laura García-Pérez, Maria Themeli
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 12
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics
Daniel C. Kirouac, Cole Zmurchok, Denise Morris
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
Qiushi Feng, Xiaofeng Shan, Vicky Yau, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 62-62
Open Access | Times Cited: 1
Microfluidic technologies for enhancing the potency, predictability and affordability of adoptive cell therapies
Zongjie Wang, Shana O. Kelley
Nature Biomedical Engineering (2025)
Closed Access | Times Cited: 1
Engaging stemness improves cancer immunotherapy
Hassan Dianat‐Moghadam, Mohammadreza Sharifi, Rasoul Salehi, et al.
Cancer Letters (2022) Vol. 554, pp. 216007-216007
Closed Access | Times Cited: 37
Applications of human organoids in the personalized treatment for digestive diseases
Qinying Wang, Fanying Guo, Yutao Jin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top